BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18174859)

  • 1. High-dose voriconazole in a critically ill pediatric patient with neuroblastoma.
    Alffenaar JW; Doedens RA; Groninger E; Kosterink JG
    Pediatr Infect Dis J; 2008 Feb; 27(2):189-90. PubMed ID: 18174859
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of voriconazole administered via a nasogastric tube to critically ill patients.
    Mohammedi I; Piens MA; Padoin C; Robert D
    Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):358-60. PubMed ID: 15875225
    [No Abstract]   [Full Text] [Related]  

  • 3. [Update on voriconazole].
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1738. PubMed ID: 12968630
    [No Abstract]   [Full Text] [Related]  

  • 4. Voriconazole in newborns.
    Kohli V; Taneja V; Sachdev P; Joshi R
    Indian Pediatr; 2008 Mar; 45(3):236-8. PubMed ID: 18367773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring plasma voriconazole levels following intravenous administration in critically ill patients: an observational study.
    Myrianthefs P; Markantonis SL; Evaggelopoulou P; Despotelis S; Evodia E; Panidis D; Baltopoulos G
    Int J Antimicrob Agents; 2010 May; 35(5):468-72. PubMed ID: 20188523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
    Brüggemann RJ; Antonius T; Heijst Av; Hoogerbrugge PM; Burger DM; Warris A
    Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
    Pascual A; Calandra T; Bolay S; Buclin T; Bille J; Marchetti O
    Clin Infect Dis; 2008 Jan; 46(2):201-11. PubMed ID: 18171251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of coccidioidal meningitis with voriconazole.
    Cortez KJ; Walsh TJ; Bennett JE
    Clin Infect Dis; 2003 Jun; 36(12):1619-22. PubMed ID: 12802765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to voriconazole.
    Boyd AE; Modi S; Howard SJ; Moore CB; Keevil BG; Denning DW
    Clin Infect Dis; 2004 Oct; 39(8):1241-4. PubMed ID: 15486850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous voriconazole therapy in a preterm infant.
    Muldrew KM; Maples HD; Stowe CD; Jacobs RF
    Pharmacotherapy; 2005 Jun; 25(6):893-8. PubMed ID: 15927909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intralesional voriconazole for the treatment of cutaneous Scedosporium apiospermum infection.
    Azofra MM; Somovilla JL; Porras MC; Carrillo LH; Pérez RD
    Clin Infect Dis; 2010 Jul; 51(2):255-7. PubMed ID: 20560740
    [No Abstract]   [Full Text] [Related]  

  • 12. Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient.
    Robatel C; Rusca M; Padoin C; Marchetti O; Liaudet L; Buclin T
    J Antimicrob Chemother; 2004 Jul; 54(1):269-70. PubMed ID: 15175271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in voriconazole trough plasma concentrations per oral dosages between children younger and older than 3 years of age.
    Shima H; Miharu M; Osumi T; Takahashi T; Shimada H
    Pediatr Blood Cancer; 2010 Jul; 54(7):1050-2. PubMed ID: 20146339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole--superior in antimycotic treatment.
    Infection; 2003 Aug; 31(4):8. PubMed ID: 14562956
    [No Abstract]   [Full Text] [Related]  

  • 15. Candidaemia secondary to intravascular catheter colonisation?
    Bal AM
    Lancet; 2006 Mar; 367(9512):728-9; author reply 729. PubMed ID: 16517269
    [No Abstract]   [Full Text] [Related]  

  • 16. Subtherapeutic itraconazole and voriconazole levels in children with cystic fibrosis.
    Bentley S; Gupta A; Balfour-Lynn IM
    J Cyst Fibros; 2013 Jul; 12(4):418-9. PubMed ID: 23103055
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulphobutylether-beta-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis.
    Burkhardt O; Thon S; Burhenne J; Welte T; Kielstein JT
    Int J Antimicrob Agents; 2010 Jul; 36(1):93-4. PubMed ID: 20381320
    [No Abstract]   [Full Text] [Related]  

  • 18. How does a patient maximally benefit from anti-infective chemotherapy?
    Drusano GL
    Clin Infect Dis; 2004 Oct; 39(8):1245-6. PubMed ID: 15486851
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
    Clifton IJ; Whitaker P; Metcalfe R; Phillip M; Shaw N; Conway SP; Peckham DG
    J Antimicrob Chemother; 2011 Oct; 66(10):2438-40. PubMed ID: 21791443
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic drug monitoring of voriconazole after intravenous administration in infants and children with primary immunodeficiency.
    Gerin M; Mahlaoui N; Elie C; Lanternier F; Bougnoux ME; Blanche S; Lortholary O; Jullien V
    Ther Drug Monit; 2011 Aug; 33(4):464-6. PubMed ID: 21743382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.